BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Receveur J, Bjurling E, Ulven T, Little PB, Nørregaard PK, Högberg T. 4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters 2004;14:5075-80. [DOI: 10.1016/j.bmcl.2004.07.077] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Witty DR, Bateson JH, Hervieu GJ, Jeffrey P, Johnson CN, Muir AI, O’hanlon PJ, Stemp G, Stevens AJ, Thewlis KM, Wilson S, Winborn KY. SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849. Bioorganic & Medicinal Chemistry Letters 2006;16:4865-71. [DOI: 10.1016/j.bmcl.2006.06.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
2 Guba W, Green LG, Martin RE, Roche O, Kratochwil N, Mauser H, Bissantz C, Christ A, Stahl M. From Astemizole to a Novel Hit Series of Small-Molecule Somatostatin 5 Receptor Antagonists via GPCR Affinity Profiling. J Med Chem 2007;50:6295-8. [DOI: 10.1021/jm701144e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
3 Méndez-Andino JL, Colson AO, Meyers KM, Mitchell MC, Hodge K, Howard JM, Kim N, Ackley DC, Holbert JK, Mittelstadt SW, Dowty ME, Obringer CM, Suchanek P, Reizes O, Hu XE, Wos JA. The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists. Bioorg Med Chem 2007;15:2092-105. [PMID: 17236777 DOI: 10.1016/j.bmc.2006.12.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
4 Frimurer TM, Ulven T, Elling CE, Gerlach LO, Kostenis E, Högberg T. A physicogenetic method to assign ligand-binding relationships between 7TM receptors. Bioorg Med Chem Lett 2005;15:3707-12. [PMID: 15993056 DOI: 10.1016/j.bmcl.2005.05.102] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
5 Chaki S, Yamaguchi J, Yamada H, Kanuma K, Sekiguchi Y. Melanin-concentrating hormone receptor 1 antagonists for the treatment of depression and anxiety. Drug Dev Res 2005;65:278-90. [DOI: 10.1002/ddr.20029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
6 Bieler M, Heilker R, Köppen H, Schneider G. Assay Related Target Similarity (ARTS) - Chemogenomics Approach for Quantitative Comparison of Biological Targets. J Chem Inf Model 2011;51:1897-905. [DOI: 10.1021/ci200105t] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
7 Guo T, Shao Y, Qian G, Rokosz LL, Stauffer TM, Hunter RC, Babu SD, Gu H, Hobbs DW. Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis. Bioorganic & Medicinal Chemistry Letters 2005;15:3696-700. [DOI: 10.1016/j.bmcl.2005.05.085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
8 Sasmal PK, Sasmal S, Rao PT, Venkatesham B, Roshaiah M, Abbineni C, Khanna I, Jadhav VP, Suresh J, Talwar R, Muzeeb S, Receveur J, Frimurer TM, Rist Ø, Elster L, Högberg T. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorganic & Medicinal Chemistry Letters 2010;20:5443-8. [DOI: 10.1016/j.bmcl.2010.07.086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vass M, Kooistra AJ, Verhoeven S, Gloriam D, de Esch IJP, de Graaf C. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number? Methods Mol Biol 2018;1705:73-113. [PMID: 29188559 DOI: 10.1007/978-1-4939-7465-8_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Eberle AN, Mild G, Zumsteg U. Cellular models for the study of the pharmacology and signaling of melanin-concentrating hormone receptors. J Recept Signal Transduct Res 2010;30:385-402. [PMID: 21083507 DOI: 10.3109/10799893.2010.524223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Garland SL. Are GPCRs Still a Source of New Targets? J Biomol Screen 2013;18:947-66. [DOI: 10.1177/1087057113498418] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 12.4] [Reference Citation Analysis]
12 Meyers KM, Kim N, Méndez-andino JL, Hu XE, Mumin RN, Klopfenstein SR, Wos JA, Mitchell MC, Paris JL, Ackley DC, Holbert JK, Mittelstadt SW, Reizes O. Aminomethyl tetrahydronaphthalene biphenyl carboxamide MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters 2007;17:814-8. [DOI: 10.1016/j.bmcl.2006.10.053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
13 Blakeney JS, Reid RC, Le GT, Fairlie DP. Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors. Chem Rev 2007;107:2960-3041. [DOI: 10.1021/cr050984g] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
14 Hudson S, Kiankarimi M, Rowbottom MW, Vickers TD, Wu D, Pontillo J, Ching B, Dwight W, Goodfellow VS, Schwarz D, Heise CE, Madan A, Wen J, Ban W, Wang H, Wade WS. Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2. Bioorganic & Medicinal Chemistry Letters 2006;16:4922-30. [DOI: 10.1016/j.bmcl.2006.06.049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
15 Meyers KM, Méndez-andino JL, Colson A, Warshakoon NC, Wos JA, Mitchell MC, Hodge KM, Howard JM, Ackley DC, Holbert JK, Mittelstadt SW, Dowty ME, Obringer CM, Reizes O, Hu XE. Aminomethyl tetrahydronaphthalene ketopiperazine MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters 2007;17:819-22. [DOI: 10.1016/j.bmcl.2006.10.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Bieler M, Koeppen H. The Role of Chemogenomics in the Pharmaceutical Industry: Chemogenomics in the Pharmaceutical Industry. Drug Dev Res 2012;73:357-64. [DOI: 10.1002/ddr.21026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Rowbottom MW, Vickers TD, Dyck B, Tamiya J, Zhang M, Zhao L, Grey J, Provencal D, Schwarz D, Heise CE, Mistry M, Fisher A, Dong T, Hu T, Saunders J, Goodfellow VS. Synthesis and structure–activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Bioorganic & Medicinal Chemistry Letters 2005;15:3439-45. [DOI: 10.1016/j.bmcl.2005.05.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Mcbriar MD, Kowalski TJ. Melanin-Concentrating Hormone as a Therapeutic Target. Annual Reports in Medicinal Chemistry Volume 40. Elsevier; 2005. pp. 119-33. [DOI: 10.1016/s0065-7743(05)40008-1] [Cited by in Crossref: 15] [Article Influence: 0.9] [Reference Citation Analysis]
19 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
20 Surgand JS, Rodrigo J, Kellenberger E, Rognan D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 2006;62:509-38. [PMID: 16294340 DOI: 10.1002/prot.20768] [Cited by in Crossref: 175] [Cited by in F6Publishing: 164] [Article Influence: 10.9] [Reference Citation Analysis]
21 Meyers KM, Méndez-andino J, Colson A, Hu XE, Wos JA, Mitchell MC, Hodge K, Howard J, Paris JL, Dowty ME, Obringer CM, Reizes O. Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists. Bioorganic & Medicinal Chemistry Letters 2007;17:657-61. [DOI: 10.1016/j.bmcl.2006.10.096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
22 Gloriam DE, Foord SM, Blaney FE, Garland SL. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem 2009;52:4429-42. [PMID: 19537715 DOI: 10.1021/jm900319e] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
23 Rowbottom MW, Vickers TD, Dyck B, Grey J, Tamiya J, Zhang M, Kiankarimi M, Wu D, Dwight W, Wade WS, Schwarz D, Heise CE, Madan A, Fisher A, Petroski R, Goodfellow VS. Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1. Bioorganic & Medicinal Chemistry Letters 2006;16:4450-7. [DOI: 10.1016/j.bmcl.2006.06.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
24 Méndez-Andino J, Colson AO, Denton D, Mitchell MC, Cross-Doersen D, Hu XE. MCH-R1 antagonists based on an arginine scaffold: SAR studies on the amino-terminus. Bioorg Med Chem Lett 2007;17:832-5. [PMID: 17107794 DOI: 10.1016/j.bmcl.2006.10.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Xuan W, Ding W, Hui H, Zhang S. Synthesis and cytotoxic activity of diaryl urea derivatives with a 4-methylpiperazinylcarbonyl moiety. Med Chem Res 2013;22:3857-62. [DOI: 10.1007/s00044-012-0398-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Nagase Y, Iida I, Yamaguchi J, Semple G, Tran T, Sekiguchi Y. Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically stable melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry 2006;14:3307-19. [DOI: 10.1016/j.bmc.2005.12.052] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
27 Goodnow R, Gillespie P. 1Hit and Lead Identification: Efficient Practices for Drug Discovery. Progress in Medicinal Chemistry Volume 45. Elsevier; 2007. pp. 1-61. [DOI: 10.1016/s0079-6468(06)45501-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
28 Ulven T, Little PB, Receveur J, Frimurer TM, Rist Ø, Nørregaard PK, Högberg T. 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: Structure–activity exploration of eastern and western parts. Bioorganic & Medicinal Chemistry Letters 2006;16:1070-5. [DOI: 10.1016/j.bmcl.2005.10.066] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
29 Rokosz LL. Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Expert Opinion on Drug Discovery 2007;2:1301-27. [DOI: 10.1517/17460441.2.10.1301] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
30 Guo T, Hunter RC, Gu H, Rokosz LL, Stauffer TM, Hobbs DW. Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis. Bioorganic & Medicinal Chemistry Letters 2005;15:3691-5. [DOI: 10.1016/j.bmcl.2005.05.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
31 Garland SL, Blaney FE. GPCR Homology Model Development and Application. Burger's Medicinal Chemistry and Drug Discovery. Wiley; 2003. pp. 279-300. [DOI: 10.1002/0471266949.bmc123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Melagraki G, Afantitis A, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-markopoulou O. Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening. J Comput Aided Mol Des 2007;21:251-67. [DOI: 10.1007/s10822-007-9112-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
33 Luthin DR. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists. Life Sci 2007;81:423-40. [PMID: 17655875 DOI: 10.1016/j.lfs.2007.05.029] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
34 Hervieu GJ. Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances. Expert Opinion on Therapeutic Targets 2006;10:211-29. [DOI: 10.1517/14728222.10.2.211] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]